Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new study has tested if a daily, 4-week intake of a multispecies probiotic improved emotional processing in people with untreated moderate depression.

Bacteria Bifidobacterium, part of normal flora of human intestine, used as probiotics and in yoghurt production.

Dietary supplementation with probiotics - live cultures of "good" bacteria - has been shown to influence brain function, but the understanding of the underlaying mechanisms involved in this remain elusive.

Associate Professor Phil Burnet, Department of Psychiatry, University of Oxford, said:


'Our study shows that taking a probiotic supplement alters emotional processing and improves mood in people with moderate depression. These data provide further evidence for gut bacteria affecting human brain function.

'Understanding the influence of probiotics on emotions may suggest how they should be most effectively combined with other interventions in the treatment of mental health conditions. People with moderate depression are often reluctant to seek medical help as they may be worried about taking medication. Our findings suggest that probiotics could be used as an early intervention to help reduce the risk of people with mild to moderate depression developing a major depressive disorder, which is more debilitating and often difficult to treat. However, it is important to note that probiotics will never, and should not, replace current pharmacological and psychological therapies.'

The study included 71 participants in a randomised double-blind, placebo-controlled trial. Results showed that the participants who took the probiotic had increased accuracy at identifying faces expressing all emotions and vigilance to neutral faces, this is different to the reported action of commonly used antidepressants, which reduce attention to negative emotions.

Associate Professor Burnet continues:

'Testing a larger population of people with other probiotics and narrowing down exactly which bacteria are influencing the processes in the periphery that lead to changes in the brain would be a helpful next step. This would then have the potential to lead to the development of new treatments for depression when conventional approaches may not be appropriate.'

Read the full paper, Multispecies probiotic administration reduces emotional salience and improves mood in subjects with moderate depression: a randomised, double-blind, placebo-controlled study.

Similar stories

Viewing self-harm images on the internet and in social media usually causes harm, according to new review

Clinical researchers have reviewed the international research evidence regarding the impact of viewing images of self-harm on the internet and in social media.

Can humans hibernate?

Illuminating new TEDx Talk from Professor of Sleep Physiology Vladyslav Vyazovskiy

European Platform for Neurodegenerative Diseases launches repository of cohorts for researchers

The new Cohort Catalogue will facilitate discovery of over 60 neurodegeneration research cohorts from 17 countries across Europe

New insights into chemogenetic designer drugs to enhance our study of behaviour

A collaborative team of researchers in DPAG and Pharmacology led by Dr Lukas Krone have uncovered striking new data demonstrating that two widely used designer drugs used to turn populations of neurons on and off in the brain cause unexpected effects on sleep. These results demonstrate a critical need to improve chemogenetic approaches in behavioural studies.

Researchers win UK Dementia Research Institute Grand Challenge Award to identify early signs of Alzheimer's

The MRC Brain Network Dynamics Unit has received funding for a multi-year research partnership designed to advance the understanding of early changes to the operations of brain circuits in Alzheimer's disease.

Ensuring LGBTQI+ people are treated fairly in mental health data

Andrey Kormilitzin outlines a new participatory study aimed at improving AI to take account of LGBTQI+ people so that their needs are better met by mental health services.